Area of research
Virology · Infectious Diseases
Research interest
Research interests include HIV Research and Treatment, HIV/AIDS drug development and treatment, Immune Cell Function and Interaction, and HIV/AIDS Research and Interventions.
Rapid elicitation of neutralizing Asn332-glycan-independent antibodies to the V3-glycan epitope of HIV-1 Env in nonhuman primates
Rapidly acquired HIV-1 neutralization breadth in a rhesus V2 apex knockin mouse model after a single bolus immunization.
Structural and genetic basis of HIV-1 envelope V2 apex recognition by rhesus broadly neutralizing antibodies
Germline-targeting HIV immunogen induces cross-neutralizing antibodies in outbred macaques
Widespread extinctions of co-diversified primate gut bacterial symbionts from humans
Small CD4 mimetics sensitize HIV-1-infected macrophages to antibody-dependent cellular cytotoxicity
Author Correction: Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
Exposure of progressive immune dysfunction by SARS-CoV-2 mRNA vaccination in patients with chronic lymphocytic leukemia: A prospective cohort study
New paternity data from Reproductive inequality among males in the genus <i>Pan</i>
New data for Nonac's B, M, and most successful sire's share from Reproductive inequality among males in the genus <i>Pan</i>
Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies
Evasion of cGAS and TRIM5 defines pandemic HIV
Detection of the HIV-1 Accessory Proteins Nef and Vpu by Flow Cytometry Represents a New Tool to Study Their Functional Interplay within a Single Infected CD4 <sup>+</sup> T Cell
DNA binding to TLR9 expressed by red blood cells promotes innate immune activation and anemia
SARS-CoV-2-specific circulating T follicular helper cells correlate with neutralizing antibodies and increase during early convalescence
Heightened resistance to host type 1 interferons characterizes HIV-1 at transmission and after antiretroviral therapy interruption
Predictors of Nonseroconversion after SARS-CoV-2 Infection
The Origin of COVID-19 and Why It Matters
Recommendations for measuring HIV reservoir size in cure-directed clinical trials
Recapitulation of HIV-1 Env-antibody coevolution in macaques leading to neutralization breadth
Convalescent plasma-mediated resolution of COVID-19 in a patient with humoral immunodeficiency
Urine as a high‐quality source of host genomic DNA from wild populations
HIV-1 Neutralizing Antibody Signatures and Application to Epitope-Targeted Vaccine Design
IFI16 Targets the Transcription Factor Sp1 to Suppress HIV-1 Transcription and Latency Reactivation
CD4 receptor diversity in chimpanzees protects against SIV infection
Primary HIV-1 Strains Use Nef To Downmodulate HLA-E Surface Expression
Sexually transmitted founder HIV-1 viruses are relatively resistant to Langerhans cell-mediated restriction
Global and regional molecular epidemiology of HIV-1, 1990–2015: a systematic review, global survey, and trend analysis
Sooty mangabey genome sequence provides insight into AIDS resistance in a natural SIV host
Tracking HIV-1 recombination to resolve its contribution to HIV-1 evolution in natural infection